Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
To evaluate the role of the functional Asn40Asp polymorphism in the mu‐opioid receptor gene on drinking behavior and naltrexone's ability to attenuate drinking, we used a daily diary method in a 12‐week, randomized clinical trial of naltrexone to reduce drinking. Participants (n = 158 problem drinkers) were assigned to receive either daily or targeted naltrexone 50 mg (n = 81) or matching placebo (n = 77). Patients reported by telephone each evening their current desire to drink and their drinking during the previous night and during the reporting day. We examined genotype, medication, desire to drink and their interactions as predictors of nighttime drinks consumed, controlling for drinking earlier in the day. Asp40 carriers showed a stronger positive association between evening desire (deviations from their mean levels) and later night drinking levels than Asn40 homozygotes (P = 0.019). The desire × genotype × medication condition interaction was also significant (P = 0.009), with a significant desire × genotype interaction for the placebo group ( P = 0.001) but not for the naltrexone group (P = 0.74). In summary, when the evening level of desire to drink was relatively high, Asp40 allele carriers were at greater risk than Asn40 homozygotes to drink more, which was attenuated by naltrexone. Although average measures across the study were not informative, daily reports helped to demonstrate the moderating effects of genetic variation on the relation between desire to drink and alcohol consumption and the effects of naltrexone on that phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ecological Momentary Assessment (Ema) in Behavioral Medicine
Stone, A. A., & Shiffman, S. (1994) · Annals of Behavioral Medicine · doi:10.1093/abm/16.3.199 · Cited by 1,931
The analysis of count data: a gentle introduction to poisson regression and its alternatives.
Coxe, S., West, S. G., & Aiken, L. S. (2009) · Journal of Personality Assessment · doi:10.1080/00223890802634175 · Cited by 1,172
Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571 · cited 2×
“Oslin et al. (2003) first reported a moderating effect of the polymorphism using data from three placebo-controlled trials of naltrexone.”
BackgroundMethodSelf-citationAnton, R. F., Oroszi, G., O’Malley, S., Couper, D., Swift, R., Pettinati, H., & Goldman, D. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.2.135 · Cited by 451 · cited 2×
“…trial of naltrexone for AD showed no evidence that the SNP moderated the effect of the medication (Gelernter et al. 2007), but a second trial showed robust moderation, at least among individuals who received medication management rather than more intensive psychotherapy (Anton et al. 2008).”
BackgroundRay, L. A., & Hutchison, K. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1069 · Cited by 258 · cited 3×
“…on the pharmacogenetics of alcohol drinking and dependence treatment (Oslin et al. 2003; McGeary et al. 2006; Gelernter et al. 2007; Mitchell et al. 2007; Ray & Hutchison 2007; Anton et al. 2008; Tidey et al. 2008; Kim et al. 2009; Ooteman et al. 2009; Coller et al. 2011; Setiawan et al. 2011).”
BackgroundDoes affect mediate the association between daily events and alcohol use?
Armeli, S., Tennen, H., Affleck, G., & Kranzler, H. R. (2000) · Journal of Studies on Alcohol · doi:10.15288/jsa.2000.61.862 · Cited by 101 · cited 1×
“Consistent with findings from published daily studies of drinking (Armeli et al. 2000; Todd et al. 2003), there were day-of-the-week effects on drinking, with subjects drinking more on Saturday nights compared with all other nights except Fridays.”
ResultSelf-citation
Cited by
Pharmacological approaches to reducing craving in patients with alcohol use disorders
Haass-Koffler, C. L., Leggio, L., & Kenna, G. A. (2014) · CNS Drugs · doi:10.1007/s40263-014-0149-3 · Cited by 83
“A double-blind RCT, which administered acamprosate for 21 days, demonstrated that acamprosate-treated patients showed significantly reduced craving, compared with placebo-treated patients [224].”
InfluentialTreatment-refractory substance use disorder: focus on alcohol, opioids, and cocaine
Soyka, M., & Mutschler, J. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.003 · Cited by 49
The effect of neuroimmune modulation on subjective response to alcohol in the natural environment
Meredith, L. R., Grodin, E. N., Montoya, A. K., Miranda, R., Squeglia, L. M., Towns, B., Evans, C., & Ray, L. A. (2022) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.14821 · Cited by 12
Metadata
- Authors
- Kranzler, H. R., Armeli, S., Covault, J., & Tennen, H.
- Venue
- Addiction Biology
- Publisher
- Wiley
- Published
- 2012-07-11
- Volume
- 18
- Issue
- 1
- Pages
- 193-201
- ISSN
- 1355-6215 (ISSN-L)
- 1369-1600
- OpenAlex
- W2140929950
- Cited by
- 49
- References
- 6
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment. https://app.cochat.ai/papers/10.1111/j.1369-1600.2012.00471.x
- The paper
- Kranzler, H. R., Armeli, S., Covault, J., & Tennen, H. (2013). Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment. Addiction Biology. https://doi.org/10.1111/j.1369-1600.2012.00471.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.